News
But this one, for Lilly’s first diabetes and weight-loss pill based on the GLP-1 hormone, was particularly fraught. Days ...
On the heels of similar investment pledges from Eli Lilly and Johnson & Johnson, Switzerland’s Novartis is stepping up to the plate with a major plan to grow its U.S. footprint. | As concerns around ...
11don MSN
Some industries have escaped these moves by the administration, at least for now. One of them is the pharmaceutical industry.
As President Trump prepares to announce pharmaceutical tariffs, he has one country, in particular, in his sights: Ireland.
Eli Lilly's oral GLP-1 drug orforglipron showed strong Phase 3 results with 7.9% weight loss and good tolerability, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback